Efficacy and Safety of mDCF as First-Line Therapy for HER2-Negative Advanced Gastric Cancer in Vietnam: A Real-World Retrospective Study
Introduction For patients with advanced gastric cancer (AGC) who are HER2-negative and ineligible for targeted therapies, chemotherapy remains the cornerstone of treatment. The modified docetaxel, cisplatin, and fluorouracil (mDCF) regimen has been proposed as an effective and tolerable triplet regi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748251371771 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|